Producer
Johnson Matthey Pharmaceutical Materials
Johnson Matthey Pharmaceutical Materials (London UK; part of Johnson Matthey plc) manufactures pharmaceutical-grade controlled substance APIs including fentanyl for licensed pharmaceutical manufacturers globally. JM operates specialized controlled substance API manufacturing under INCB quota. Johnson Matthey is simultaneously the world's largest platinum catalyst company and a critical pharmaceutical API manufacturer — the same company supplying automotive catalytic converters also supplies ICU fentanyl.
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input Johnson Matthey Pharmaceutical Materials supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Johnson Matthey Pharmaceutical Materials makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Controlled Substance APIs (Fentanyl, Opioids)
55%Platinum Compound APIs (Cisplatin precursors)
30%Specialty Pharma Catalysts & Materials
15%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2022
Johnson Matthey plc (London) simultaneously manufactures platinum group metal catalysts for automotive catalytic converters (reducing vehicle emissions) AND pharmaceutical-grade controlled substance APIs including fentanyl for medical use. The same company — best known as the world's largest supplier of platinum catalyst for automobiles — holds DEA and international INCB authorizations to manufacture Schedule II narcotic APIs. Johnson Matthey's pharmaceutical materials division is entirely legal and regulated, but represents an extraordinary dual-purpose industrial profile that bridges vehicle emissions control and hospital pain management.
Johnson Matthey plc ↗Origin2023
Johnson Matthey Pharmaceutical Materials traces to JM's century-long expertise in platinum group metals refining and precious metal catalysis. JM developed pharmaceutical-grade PGM capabilities by applying its platinum refining expertise to medical-grade compound synthesis — the same purity control that produces laboratory platinum standards also produces pharmaceutical-grade platinum compounds (cisplatin, carboplatin precursors). JM expanded into controlled substance manufacturing by leveraging its UK chemistry and regulatory capabilities: UK Drug Enforcement controls allow UK manufacturers to export Schedule I/II controlled substances under international treaty licensing, giving JM access to global pharmaceutical fentanyl and opioid markets from its UK and US facilities.
Johnson Matthey PLC ↗